top TOP
July 5, 2023

Rony Dahan, PhD

Weizmann Institute of Science

ICRF Project Grant

The immune response fights cancer, and much effort has been devoted to developing strategies that stimulate immune cells to eliminate tumors from the body. The CD40 antibody is a key player in this process, but can produce toxicity when applied in high doses. Dr. Dahan’s lab is investigating ways to generate new versions of CD40 in the hopes of creating an optimized human antibody for cancer immunotherapy. 

Help End the Suffering Caused By Cancer

The answer to cancer is research. Support groundbreaking cancer research in Israel today: